Erin Luea is the Senior Scientist in the Toxicology Department. She brings more than 13 years of drug development experience in the execution, design, conduction, project management and reporting of regulated toxicology studies in support of IND applications for pharmaceutical and biotechnology companies.
Luea’s experience includes in vivo toxicology studies, safety pharmacology, safety pharmacology, and pharmacokinetic assessments in multiple species. She has detailed knowledge of FDA and OECD guidances that pertain to the design and conduct of general and specialized toxicology studies. Her areas of expertise include the safety assessment of oncolytic therapeutics and viral vectors. Luea also has more than 11 years of project team experience and has managed many outsourced bioanalytical, pharmacokinetic, and GLP toxicology studies. She has been on the project teams for more than 20 IND submissions for regulatory approval and has successfully fielded investigator questions during the approval process.
May 9, 2024
April 11, 2024
March 13, 2024